Sinbaglustat

N/A

Report date: 2023/11/29 17:36:51
NME

Base Information

Drug NameSinbaglustat
Drug Alias NameACT-519276OGT-2378(Idorsia)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCeramide glucosyltransferase inhibitorsBeta-glucocerebrosidase inhibitors
TargetsCeramide glucosyltransferaseBeta-glucocerebrosidase
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIdorsia Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIdorsia Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank